...05-A3应用电路板信息应用注释1590 LM3405 演示板应用注释1399 LMH1981评估板指导手册 应用注释1604 非完全补偿（Decompensated）运算放大器 应用注释1564 由LXT971/972A至DP83848C/I/YB PHYTER 系统的滚动支持文件 应用注释1563 采用LM5574和LM25574的0.5安培...
基于4个网页-相关网页
Decompensated liver cirrhosis 失代偿期肝硬化 ; 失代偿肝硬化 ; 失代偿性肝硬化
Decompensated cirrhosis 失代偿期肝硬化 ; 失代偿肝硬化
acute decompensated heart failure 急性失代偿性心力衰竭 ; 急性失代偿性心衰 ; 急性失代偿心衰
decompensated metabolic acidosis 失代偿性代谢性酸中毒
Decompensated CHF 失代偿心力衰竭
Decompensated heart failure 失代偿性心力衰竭
Acute decompensated HF 急性失代偿心力衰竭
Decompensated Amplifiers 非完全补偿放大器
Compared to control group and compensated cirrhosis group,the MTT of decompensated cirrhosis group significantly decreased(both 0.05>P >0.01).
失代偿期肝硬化组的MTT值较正常对照组和代偿期肝硬化组减少,组间差别有统计学意义(0.05>P>0.01)。
参考来源 - 肝硬化患者肺微循环多层螺旋CT灌注研究·2,447,543篇论文数据，部分数据来源于NoteExpress
Clinical Observation of Lamivudine for Decompensated Cirrhosis Resulting from Chronic Hepatitis b.
拉米夫定治疗乙型肝炎肝硬化失代偿期的临床观察。
Effect of health educational intervention on life quality of patients with decompensated liver cirrhosis.
健康教育干预对肝硬化失代偿期患者生活质量的影响。
Methods: Normal cases compensated cirrhosis and decompensated cirrhosis each 100 cases respectively were selected at random.
方法：随机选择正常肝脏、代偿期和失代偿期肝硬化各100例。
应用推荐